Jenburkt Pharmaceuticals Ltd has informed BSE that the Company has been awarded an NSIC-CRISIL rating of "NSIC-CRISIL SE-1A" on June 30, 2011. The rating indicates "Highest performance capability and High financial strength". This rating is valid till June 29, 2012. Jenburkt Pharmaceuticals Limited has been rated under the same category for the fourth year in continuation.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
